Nuclear Medicine in Clinical Oncology Current Status and Future Aspects

Nuclear Medicine in Clinical Oncology Current Status and Future Aspects / edited by Cuno Winkler.

The introduction of nuclear medicine into oncology dates back to the early 1 940s, when Lawrence reported on the tumor retention of 32P-phosphate, von Hevesy and von Euler soon afterwards published their fundamental work on the metabolism of phosphorus in sarcoma cells, and when almost at the same t...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Winkler, Cuno (Editor)
Format: eBook
Language:English
Published: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 1986.
Edition:1st ed. 1986.
Series:Springer eBook Collection.
Subjects:
Nuclear medicine.
Oncology  .
Electronic resources (E-books)
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.
Table of Contents:
  • I. Introduction and Basic Considerations
  • Nuclear Oncology: Current Role and Future Direction
  • Nuclear Principles of Tumor Detection
  • Mechanisms Responsible for Radioactive Tracer Uptake in Malignancies
  • II. Technical Principles
  • Gamma Camera Imaging and Single Probe Detection of Tumors
  • Single Photon and Positron Emission Computerized Tomography in Tumor Diagnosis
  • NMR Tomography of Cancer: Technical Considerations
  • Parameter-Selective Proton NMR Imaging and Tissue Characterization In Vivo
  • Development of Magnetic Resonance Contrast Media for Tumors
  • Computer-Assisted Echographic Tissue Characterization in Tumor Diagnostics
  • III. Diagnostic Use of Radiopharmaceuticals
  • Clinical Aspects of Detection and Imaging of Brain Tumors
  • Noncontact Eye Tumor Imaging with a Gamma Camera
  • Clinical Aspects of Detection and Imaging of Differentiated Thyroid Tumors
  • Clinical Aspects of Detection and Imaging of Lung Tumors
  • Clinical Aspects of Detection and Imaging of Tumors of Liver and Spleen
  • Use of Scintigraphy for Evaluation of Patients with Renal Malignancies
  • Scintigraphy of Lymphokinetics and Lymphatic Neoplasia
  • Bone Scintigraphy in Primary Malignant Bone Tumor
  • Scintigraphic Detection of Bone Metastases
  • Metaiodobenzylguanidine in the Diagnosis of Neuroblastomas
  • Scintigraphic Imaging of Pheochromocytomas by Means of Metaiodobenzylguanidine (MIBG)
  • Nuclear Medicine in the Diagnosis of Skin Tumors
  • IV. Radioimmunodetection
  • Principles of Radioimmunodetection of Tumors
  • Immunoscintigraphy of CEA-Producing Tumors with Special Emphasis on the Use of Mab Fragments and ECT
  • Beta-hCG and Related Germ Cell Tumor Antigens in Radioimmunodetection
  • Radioimmunodetection with Monoclonal Antibodies Against Prostatic Acid Phosphatase
  • Immunoscintigraphy of Ovarian Cancer by Means of HMFG2 Monoclonal Antibody
  • Immunoscintigraphy of Gynaecological Tumors
  • Radioimmunoscintigraphy by Means of Melanoma Antibody
  • Radioimmunoscintigraphy of CA 19-9/CEA Producing Tumors Using I-131 Labeled F (ab?)2 Fragments of Monoclonal Antibodies (19-9/Anti-CEA Radioimmunococktail)
  • Radioimmunodetection of Malignant Melanoma with Radiolabelled (131I, 123I, 111In, 99mTc) Monoclonal Antibodies and F (ab?)2 Fragments
  • Imaging of Bone and Soft Tissue Tumors Using an Antitumor Monoclonal Antibody
  • V. Nuclear Magnetic Resonance Imaging and In Vivo Spectroscopy
  • Current Status of Magnetic Resonance Imaging of the Central Nervous System
  • NMR Imaging of Tumors in the Body Stem
  • NMR In Vivo Spectroscopy in Tumor Diagnosis
  • VI. Positron Emission Tomography
  • Production and Use of Positron-Emitting Test Substances for Tumor Diagnosis
  • Uptake of 11C-Aminocyclopentane Carboxylic Acid (ACPC) and 13N-Ammonia in Malignant Tumors. A Comparative Clinical Study
  • Analysis of Brain Tumor Physiology by Positron Emission Tomography
  • VII. Use of Tumor Markers In Vitro
  • Overview of the Development of Tumor Markers
  • The Clinical Value of Tumor-Associated Proteins in Gastrointestinal Cancer
  • The Value of Tumor Markers in the Diagnosis of Urogenital Carcinoma
  • Tumor Markers for Monitoring Therapy in Lung Cancer
  • Tumor Markers for Follow-Up of Thyroid Carcinoma
  • Use of Tumor Markers for Patient Monitoring in Breast Cancer
  • Tumor Markers for Monitoring Breast Cancer Patients
  • VIII. Therapeutic Use of Radiopharmaceuticals Including Labelled Antibodies
  • Radioiodine Treatment of Thyroid Carcinomas
  • Therapy of the Neuroblastoma with 131I-MIBG
  • Treatment of Pheochromocytomas with 131I-Metaiodobenzylguanidine
  • Treatment of Neuroblastoma by 131I-Metaiodobenzylguanidine (131I-MIBG): Qualitative and Quantitative Scintigraphic Evaluation of the Treatment Effect
  • Endolymphatic Radionuclide Therapy (ELRT) in Malignant Melanoma of the Lower Extremities
  • On the Efficacy of Strontium-89 Therapy. Preliminary Evaluation of a Double-blind Study
  • Cancer Treatment with Radioactive Labeled Antibodies
  • Treatment of Pleural and Peritoneal Carcinosis with Radioactive Colloids
  • Treatment of Hepatic Malignancies by Intravascular Administration of Radioisotopes
  • Treatment of Local Prostatic Cancer by 125Iodine Seeds
  • CT-Guided Stereotactic Implantation with Iridium-192 and Iodine-125 of Non-Resectable Intracranial Tumors
  • IX. Experimental Approaches and Future Aspects
  • Radioimmunodetection of Hodgkin Tumors in Nude Mice
  • Immunoscintigraphy of Human Pancreatic Carcinoma in Nude Mice with F(ab?)2 Fragments of Monoclonal Antibodies to CA 19-9 and CEA
  • Physico-chemical Properties and Biokinetics of Tumor-Affine Metal (M)-Ligand-Complexes
  • Iodoazomycin Riboside [1-(5?-iodo-5?-deoxyribofuranosyl)-2-nitroimidazole],a Hypoxic Cell Marker. In Vivo Evaluation in Experimental Tumors]
  • The Potential Use of Alpha and Auger-Electron Emitting Radionuclides for Therapy
  • Studies on the In Vivo Stability of 211At Labelled Albumin Particles in Mice.

Similar Items